PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31352515-0	2019	Long noncoding RNA CASC2 promotes paclitaxel resistance in breast cancer through regulation of miR-18a-5p/CDK19.	Paclitaxel	34-44	cyclin dependent kinase 19	Homo sapiens	106-111	
31352515-13	2019	In summary, we identified that CASC2 activated PTX resistance in breast cancer through regulation of miR-18a-5p/CDK19.	Paclitaxel	47-50	cyclin dependent kinase 19	Homo sapiens	112-117	
27207777-0	2016	Cyclin-Dependent Kinase 11 (CDK11) Is Required for Ovarian Cancer Cell Growth In Vitro and In Vivo, and Its Inhibition Causes Apoptosis and Sensitizes Cells to Paclitaxel.	Paclitaxel	160-170	cyclin dependent kinase 19	Homo sapiens	0-26	
27207777-0	2016	Cyclin-Dependent Kinase 11 (CDK11) Is Required for Ovarian Cancer Cell Growth In Vitro and In Vivo, and Its Inhibition Causes Apoptosis and Sensitizes Cells to Paclitaxel.	Paclitaxel	160-170	cyclin dependent kinase 19	Homo sapiens	28-33	
27207777-7	2016	Moreover, CDK11 knockdown enhances the cytotoxic effect of paclitaxel to inhibit cell growth in ovarian cancer cells.	Paclitaxel	59-69	cyclin dependent kinase 19	Homo sapiens	10-15